Zosano Pharma Corporation filed an amended disclosure statement in the US Bankruptcy Court on October 10, 2022. As per the amended statement filed, general unsecured claims are of $10.72 million with recovery expected recovery between 31% and 34%.
Zosano Pharma Corporation
Equities
ZSAN
US98979H3012
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |